Last reviewed · How we verify
Maltodextrin (Placebo)
Maltodextrin is an inert carbohydrate polymer that serves as a placebo control with no active pharmacological mechanism.
Maltodextrin is an inert carbohydrate polymer that serves as a placebo control with no active pharmacological mechanism. Used for Used as placebo control in clinical trials (not a therapeutic indication).
At a glance
| Generic name | Maltodextrin (Placebo) |
|---|---|
| Also known as | Globe Plus 10 DE Maltodextrin, Univar, Canada, Intervention group, Placebo |
| Sponsor | Jeff Taekman, M.D. |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Maltodextrin is a polysaccharide derived from starch that is physiologically inert and provides no therapeutic effect. It is commonly used as a placebo comparator in clinical trials to establish baseline efficacy and safety profiles of investigational drugs. The substance is absorbed and metabolized as a simple carbohydrate without targeting any specific molecular pathway.
Approved indications
- Placebo control in clinical trials
Common side effects
- Gastrointestinal effects (if any)
Key clinical trials
- The Effect of NP-2006 on Sleep Quality and Health (NA)
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
- Prebiotics, Gut Microbiota, and Cardiometabolic Health (NA)
- Short Term Choline and Cardiovascular Health (NA)
- Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults (NA)
- To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants (PHASE2)
- Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease (PHASE2)
- Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Maltodextrin (Placebo) CI brief — competitive landscape report
- Maltodextrin (Placebo) updates RSS · CI watch RSS
- Jeff Taekman, M.D. portfolio CI